In the last 12 months, insiders at Zymeworks Inc. ($ZYME) filed 187 transactions with the SEC: 47 open-market purchases totaling $107,392,415 and 23 sales totaling $6,470,551. Net insider sentiment: net buying.
Zymeworks Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- EcoR1 Capital, LLC (Director) — 39 transactions totaling $58,037,083
- EcoR1 Capital, LLC (TenPercentOwner) — 10 transactions totaling $47,756,362
- Ciongoli Gregory Austin (Not found) — 4 transactions totaling $4,988,300
- Galbraith Kenneth (Chair & CEO) — 31 transactions totaling $4,450,832
- EcoR1 Capital, LLC (Not found) — 1 transaction totaling $1,600,000
View all SEC Filings for Zymeworks Inc. (ZYME).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Cherry Brian N | Not found | A | Stock Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 75,775,214 | 9999.99% | 0.03% |
| Jan. 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | A | Performance Stock Unit | 66000 | $0.00 | 66,000.0000 | 75,775,214 | 9999.99% | 0.09% |
| Jan. 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | A | Restricted Stock Unit | 47000 | $0.00 | 47,000.0000 | 75,775,214 | 9999.99% | 0.06% |
| Jan. 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 75,775,214 | 9999.99% | 0.09% |
| Jan. 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | M | Restricted Stock Unit | 17666 | $0.00 | 35,334.0000 | 75,775,214 | 33.33% | 0.02% |
| Jan. 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | S | Common Stock | 6120 | $22.67 | 132,913.0000 | 75,775,214 | 4.40% | 0.01% |
| Jan. 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | M | Common Stock | 17666 | $0.00 | 139,033.0000 | 75,775,214 | 14.56% | 0.02% |
| Jan. 12, 2026 | Cherry Brian N | Not found | A | Restricted Stock Unit | 15400 | $0.00 | 15,400.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | S | Common Stock | 9310 | $22.67 | 26,708.0000 | 75,775,214 | 25.85% | 0.01% |
| Jan. 12, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | M | Restricted Stock Unit | 17666 | $0.00 | 35,334.0000 | 75,775,214 | 33.33% | 0.02% |
| Jan. 12, 2026 | Ciongoli Gregory Austin | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Ciongoli Gregory Austin | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 12, 2026 | Neu Kelvin | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Neu Kelvin | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 12, 2026 | Landry Robert E | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Landry Robert E | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 12, 2026 | Cesano Alessandra | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Cesano Alessandra | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 12, 2026 | Campoy Carlos | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Campoy Carlos | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 12, 2026 | Mahony Susan | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Mahony Susan | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | M | Common Stock | 17666 | $0.00 | 58,057.0000 | 75,775,214 | 43.74% | 0.02% |
| Jan. 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 9560 | $22.67 | 48,497.0000 | 75,775,214 | 16.47% | 0.01% |
| Jan. 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | M | Restricted Stock Unit | 17666 | $0.00 | 35,334.0000 | 75,775,214 | 33.33% | 0.02% |
| Jan. 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 75,775,214 | 9999.99% | 0.09% |
| Jan. 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | A | Restricted Stock Unit | 47000 | $0.00 | 47,000.0000 | 75,775,214 | 9999.99% | 0.06% |
| Jan. 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | A | Performance Stock Unit | 66000 | $0.00 | 66,000.0000 | 75,775,214 | 9999.99% | 0.09% |
| Jan. 12, 2026 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 64000 | $0.00 | 257,266.0000 | 75,775,214 | 33.11% | 0.08% |
| Jan. 12, 2026 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 30424 | $22.67 | 226,842.0000 | 75,775,214 | 11.83% | 0.04% |
| Jan. 12, 2026 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 64000 | $0.00 | 128,000.0000 | 75,775,214 | 33.33% | 0.08% |
| Jan. 12, 2026 | Galbraith Kenneth | Chair & CEO | A | Stock Option (Right to Buy) | 216000 | $0.00 | 216,000.0000 | 75,775,214 | 9999.99% | 0.29% |
| Jan. 12, 2026 | Galbraith Kenneth | Chair & CEO | A | Restricted Stock Unit | 144000 | $0.00 | 144,000.0000 | 75,775,214 | 9999.99% | 0.19% |
| Jan. 12, 2026 | Galbraith Kenneth | Chair & CEO | A | Performance Stock Unit | 222000 | $0.00 | 222,000.0000 | 75,775,214 | 9999.99% | 0.29% |
| Jan. 12, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | M | Common Stock | 17666 | $0.00 | 36,018.0000 | 75,775,214 | 96.26% | 0.02% |
| Jan. 6, 2026 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | A | Common Stock | 459 | $10.55 | 459.0000 | 75,775,214 | 9999.99% | 0.00% |
| Jan. 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | M | Restricted Stock Unit | 17168 | $0.00 | 0.0000 | 75,775,214 | 100.00% | 0.02% |
| Jan. 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | M | Common Stock | 20000 | $0.00 | 51,212.0000 | 75,775,214 | 64.08% | 0.03% |
| Jan. 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 10821 | $25.10 | 40,391.0000 | 75,775,214 | 21.13% | 0.01% |
| Jan. 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | M | Restricted Stock Unit | 20000 | $0.00 | 20,000.0000 | 75,775,214 | 50.00% | 0.03% |
| Jan. 5, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | M | Common Stock | 20000 | $0.00 | 28,890.0000 | 75,775,214 | 224.97% | 0.03% |
| Jan. 5, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | S | Common Stock | 10538 | $25.10 | 18,352.0000 | 75,775,214 | 36.48% | 0.01% |
| Jan. 5, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | M | Restricted Stock Unit | 20000 | $0.00 | 20,000.0000 | 75,775,214 | 50.00% | 0.03% |
| Jan. 5, 2026 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 47668 | $0.00 | 180,943.0000 | 75,775,214 | 35.77% | 0.06% |
| Jan. 5, 2026 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 22657 | $25.10 | 158,286.0000 | 75,775,214 | 12.52% | 0.03% |
| Jan. 5, 2026 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 66666 | $0.00 | 224,952.0000 | 75,775,214 | 42.12% | 0.09% |
| Jan. 5, 2026 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 31686 | $25.10 | 193,266.0000 | 75,775,214 | 14.09% | 0.04% |
| Jan. 5, 2026 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 47668 | $0.00 | 0.0000 | 75,775,214 | 100.00% | 0.06% |
| Jan. 5, 2026 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 66666 | $0.00 | 66,668.0000 | 75,775,214 | 50.00% | 0.09% |
| Jan. 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | M | Common Stock | 17168 | $0.00 | 40,501.0000 | 75,775,214 | 73.58% | 0.02% |
| Jan. 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 9289 | $25.10 | 31,212.0000 | 75,775,214 | 22.94% | 0.01% |
| Dec. 22, 2025 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 47528 | $27.02 | 133,275.0000 | 75,775,214 | 26.29% | 0.06% |
| Dec. 22, 2025 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 100000 | $0.00 | 180,803.0000 | 75,775,214 | 123.76% | 0.13% |
| Dec. 22, 2025 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 100000 | $0.00 | 0.0000 | 75,775,214 | 100.00% | 0.13% |
| Aug. 11, 2025 | Landry Robert E | Not found | A | Stock Option (Right to Buy) | 62000 | $0.00 | 62,000.0000 | 75,878,738 | 9999.99% | 0.08% |
| Aug. 12, 2025 | Ciongoli Gregory Austin | Not found | A | Common Stock | 415000 | $12.02 | 493,500.0000 | 75,878,738 | 528.66% | 0.55% |
| Aug. 11, 2025 | Ciongoli Gregory Austin | Not found | A | Stock Option (Right to Buy) | 62000 | $0.00 | 62,000.0000 | 75,878,738 | 9999.99% | 0.08% |
| June 26, 2025 | EcoR1 Capital, LLC | Director | X | Pre-Funded Warrants (right to acquire) | 5086521 | $0.00 | 0.0000 | 75,878,738 | 100.00% | 6.70% |
| June 26, 2025 | EcoR1 Capital, LLC | Director | F | Common Stock | 41 | $12.71 | 22,970,388.0000 | 75,878,738 | 0.00% | 0.00% |
| June 26, 2025 | EcoR1 Capital, LLC | Director | X | Common Stock | 5086480 | $0.00 | 22,970,388.0000 | 75,878,738 | 28.44% | 6.70% |
| May 15, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 49502 | $11.43 | 17,877,989.0000 | 75,878,738 | 0.28% | 0.07% |
| May 19, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 5919 | $11.78 | 17,883,908.0000 | 75,878,738 | 0.03% | 0.01% |
| April 16, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 73953 | $11.16 | 17,773,727.0000 | 75,878,738 | 0.42% | 0.10% |
| April 17, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 54760 | $11.52 | 17,828,487.0000 | 75,878,738 | 0.31% | 0.07% |
| April 3, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 120770 | $11.84 | 17,503,336.0000 | 75,878,738 | 0.69% | 0.16% |
| April 4, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 196438 | $11.17 | 17,699,774.0000 | 75,878,738 | 1.12% | 0.26% |
| March 31, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 4397 | $11.75 | 17,259,548.0000 | 75,878,738 | 0.03% | 0.01% |
| April 1, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 48658 | $11.60 | 17,308,206.0000 | 75,878,738 | 0.28% | 0.06% |
| April 2, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 74360 | $11.85 | 17,382,566.0000 | 75,878,738 | 0.43% | 0.10% |
| March 25, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 53501 | $12.91 | 17,211,303.0000 | 75,878,738 | 0.31% | 0.07% |
| March 26, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 43848 | $12.24 | 17,255,151.0000 | 75,878,738 | 0.25% | 0.06% |
| March 20, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 73476 | $12.93 | 17,104,080.0000 | 75,878,738 | 0.43% | 0.10% |
| March 21, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 31033 | $12.78 | 17,135,113.0000 | 75,878,738 | 0.18% | 0.04% |
| March 24, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 22689 | $13.08 | 17,157,802.0000 | 75,878,738 | 0.13% | 0.03% |
| March 17, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 56277 | $12.23 | 16,858,418.0000 | 75,878,738 | 0.33% | 0.07% |
| March 18, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 113880 | $12.65 | 16,972,298.0000 | 75,878,738 | 0.68% | 0.15% |
| March 19, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 58306 | $12.64 | 17,030,604.0000 | 75,878,738 | 0.34% | 0.08% |
| March 11, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 320690 | $11.49 | 16,040,851.0000 | 75,878,738 | 2.04% | 0.42% |
| March 12, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 292934 | $12.25 | 16,333,785.0000 | 75,878,738 | 1.83% | 0.39% |
| March 13, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 468356 | $12.48 | 16,802,141.0000 | 75,878,738 | 2.87% | 0.62% |
| Jan. 16, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 121681 | $13.89 | 15,700,413.0000 | 75,878,738 | 0.78% | 0.16% |
| Jan. 17, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 19748 | $13.87 | 15,720,161.0000 | 75,878,738 | 0.13% | 0.03% |
| Jan. 14, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 54500 | $13.56 | 15,539,703.0000 | 75,878,738 | 0.35% | 0.07% |
| Jan. 13, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 74125 | $13.39 | 15,485,203.0000 | 75,878,738 | 0.48% | 0.10% |
| Jan. 15, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 39029 | $14.01 | 15,578,732.0000 | 75,878,738 | 0.25% | 0.05% |
| Jan. 10, 2025 | Galbraith Kenneth | Chair & CEO | A | Stock Option (Right to Buy) | 288000 | $0.00 | 288,000.0000 | 75,878,738 | 9999.99% | 0.38% |
| Jan. 10, 2025 | Smith Jeffrey T L | EVP & Chief Medical Officer | A | Restricted Stock Unit | 53000 | $0.00 | 53,000.0000 | 75,878,738 | 9999.99% | 0.07% |
| Jan. 10, 2025 | Smith Jeffrey T L | EVP & Chief Medical Officer | A | Stock Option (Right to Buy) | 79000 | $0.00 | 79,000.0000 | 75,878,738 | 9999.99% | 0.10% |
| Jan. 10, 2025 | Moore Paul Andrew | Chief Scientific Officer | A | Restricted Stock Unit | 53000 | $0.00 | 53,000.0000 | 75,878,738 | 9999.99% | 0.07% |
| Jan. 10, 2025 | Moore Paul Andrew | Chief Scientific Officer | A | Stock Option (Right to Buy) | 79000 | $0.00 | 79,000.0000 | 75,878,738 | 9999.99% | 0.10% |
| Jan. 10, 2025 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | A | Restricted Stock Unit | 53000 | $0.00 | 53,000.0000 | 75,878,738 | 9999.99% | 0.07% |
| Jan. 10, 2025 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | A | Stock Option (Right to Buy) | 79000 | $0.00 | 79,000.0000 | 75,878,738 | 9999.99% | 0.10% |
| Jan. 10, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 204098 | $13.13 | 15,411,078.0000 | 75,878,738 | 1.34% | 0.27% |
| Jan. 10, 2025 | Galbraith Kenneth | Chair & CEO | A | Restricted Stock Unit | 192000 | $0.00 | 192,000.0000 | 75,878,738 | 9999.99% | 0.25% |
| Jan. 8, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 21021 | $14.07 | 15,206,980.0000 | 75,878,738 | 0.14% | 0.03% |
| Jan. 6, 2025 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 47666 | $0.00 | 71,428.0000 | 75,878,738 | 200.60% | 0.06% |
| Jan. 6, 2025 | Moore Paul Andrew | Chief Scientific Officer | M | Common Stock | 17166 | $0.00 | 24,533.0000 | 75,878,738 | 233.01% | 0.02% |
| Jan. 6, 2025 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 9792 | $14.92 | 14,741.0000 | 75,878,738 | 39.91% | 0.01% |
| Jan. 6, 2025 | Moore Paul Andrew | Chief Scientific Officer | M | Common Stock | 20000 | $0.00 | 34,741.0000 | 75,878,738 | 135.68% | 0.03% |
| Jan. 6, 2025 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 11408 | $14.92 | 23,333.0000 | 75,878,738 | 32.84% | 0.02% |
| Jan. 6, 2025 | Moore Paul Andrew | Chief Scientific Officer | M | Restricted Stock Unit | 17166 | $0.00 | 17,168.0000 | 75,878,738 | 50.00% | 0.02% |
| Jan. 6, 2025 | Moore Paul Andrew | Chief Scientific Officer | M | Restricted Stock Unit | 20000 | $0.00 | 40,000.0000 | 75,878,738 | 33.33% | 0.03% |
| Jan. 6, 2025 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 23885 | $14.92 | 47,543.0000 | 75,878,738 | 33.44% | 0.03% |
| Jan. 6, 2025 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 66666 | $0.00 | 114,209.0000 | 75,878,738 | 140.22% | 0.09% |
| Jan. 6, 2025 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 33406 | $14.92 | 80,803.0000 | 75,878,738 | 29.25% | 0.04% |
| Jan. 6, 2025 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 47666 | $0.00 | 47,668.0000 | 75,878,738 | 50.00% | 0.06% |
| Jan. 6, 2025 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 66666 | $0.00 | 133,334.0000 | 75,878,738 | 33.33% | 0.09% |
| Jan. 6, 2025 | Smith Jeffrey T L | EVP & Chief Medical Officer | M | Common Stock | 20000 | $0.00 | 20,000.0000 | 75,878,738 | 9999.99% | 0.03% |
| Jan. 6, 2025 | Smith Jeffrey T L | EVP & Chief Medical Officer | S | Common Stock | 11110 | $14.92 | 8,890.0000 | 75,878,738 | 55.55% | 0.01% |
| Jan. 6, 2025 | Smith Jeffrey T L | EVP & Chief Medical Officer | M | Restricted Stock Unit | 20000 | $0.00 | 40,000.0000 | 75,878,738 | 33.33% | 0.03% |
| Dec. 30, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 58988 | $14.47 | 14,881,578.0000 | 76,266,177 | 0.40% | 0.08% |
| Jan. 2, 2025 | EcoR1 Capital, LLC | Director | P | Common Stock | 157880 | $14.78 | 15,185,959.0000 | 75,878,738 | 1.05% | 0.21% |
| Dec. 31, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 146501 | $14.57 | 15,028,079.0000 | 76,266,177 | 0.98% | 0.19% |
| Dec. 26, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 16692 | $14.38 | 14,720,931.0000 | 76,266,177 | 0.11% | 0.02% |
| Dec. 27, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 101659 | $14.49 | 14,822,590.0000 | 76,266,177 | 0.69% | 0.13% |
| Dec. 24, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 11958 | $14.12 | 14,704,239.0000 | 76,266,177 | 0.08% | 0.02% |
| Dec. 19, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 298818 | $13.53 | 13,736,291.0000 | 76,266,177 | 2.22% | 0.39% |
| Dec. 20, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 704488 | $14.08 | 14,440,779.0000 | 76,266,177 | 5.13% | 0.92% |
| Dec. 23, 2024 | EcoR1 Capital, LLC | Director | P | Common Stock | 251502 | $14.25 | 14,692,281.0000 | 76,266,177 | 1.74% | 0.33% |
| Dec. 26, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Pre-Funded Warrants | 5086521 | $9.83 | 5,086,521.0000 | 65,249,184 | 9999.99% | 7.80% |
| Dec. 10, 2024 | Gallagher Neil | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Miller Derek John Michael | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Campoy Carlos | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Cesano Alessandra | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Neu Kelvin | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Davidson Nancy | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Cox Troy | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Dec. 10, 2024 | Mahony Susan | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| Sept. 1, 2024 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 68,863,010 | 9999.99% | 0.52% |
| April 2, 2024 | Gallagher Neil | Not found | A | Stock Option (Right to Buy) | 74000 | $0.00 | 74,000.0000 | 68,863,010 | 9999.99% | 0.11% |
| Feb. 8, 2024 | Cesano Alessandra | Not found | A | Stock Option (Right to Buy) | 74000 | $0.00 | 74,000.0000 | 68,863,010 | 9999.99% | 0.11% |
| Jan. 8, 2024 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 5706 | $11.22 | 23,762.0000 | 68,863,010 | 19.36% | 0.01% |
| Jan. 5, 2024 | Astle Christopher | SVP & Chief Financial Officer | S | Common Stock | 4563 | $10.65 | 7,934.0000 | 68,863,010 | 36.51% | 0.01% |
| Jan. 8, 2024 | Astle Christopher | SVP & Chief Financial Officer | S | Common Stock | 1431 | $11.22 | 6,503.0000 | 68,863,010 | 18.04% | 0.00% |
| Jan. 5, 2024 | Astle Christopher | SVP & Chief Financial Officer | M | Restricted Stock Unit | 10500 | $0.00 | 21,000.0000 | 68,863,010 | 33.33% | 0.02% |
| Jan. 5, 2024 | Astle Christopher | SVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 68,863,010 | 9999.99% | 0.07% |
| Jan. 5, 2024 | Astle Christopher | SVP & Chief Financial Officer | A | Restricted Stock Unit | 30000 | $0.00 | 30,000.0000 | 68,863,010 | 9999.99% | 0.04% |
| Jan. 5, 2024 | Moore Paul Andrew | Chief Scientific Officer | M | Common Stock | 17166 | $0.00 | 17,166.0000 | 68,863,010 | 9999.99% | 0.02% |
| Jan. 5, 2024 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 7460 | $10.65 | 9,706.0000 | 68,863,010 | 43.46% | 0.01% |
| Jan. 8, 2024 | Moore Paul Andrew | Chief Scientific Officer | S | Common Stock | 2339 | $11.22 | 7,367.0000 | 68,863,010 | 24.10% | 0.00% |
| Jan. 5, 2024 | Moore Paul Andrew | Chief Scientific Officer | M | Restricted Stock Unit | 17166 | $0.00 | 34,334.0000 | 68,863,010 | 33.33% | 0.02% |
| Jan. 5, 2024 | Moore Paul Andrew | Chief Scientific Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 68,863,010 | 9999.99% | 0.13% |
| Jan. 5, 2024 | Moore Paul Andrew | Chief Scientific Officer | A | Restricted Stock Unit | 60000 | $0.00 | 60,000.0000 | 68,863,010 | 9999.99% | 0.09% |
| Jan. 5, 2024 | Smith Jeffrey T L | EVP & Chief Medical Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 68,863,010 | 9999.99% | 0.13% |
| Jan. 5, 2024 | Smith Jeffrey T L | EVP & Chief Medical Officer | A | Restricted Stock Unit | 60000 | $0.00 | 60,000.0000 | 68,863,010 | 9999.99% | 0.09% |
| Jan. 5, 2024 | Galbraith Kenneth | Chair & CEO | A | Restricted Stock Unit | 200000 | $0.00 | 200,000.0000 | 68,863,010 | 9999.99% | 0.29% |
| Jan. 5, 2024 | Galbraith Kenneth | Chair & CEO | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 68,863,010 | 9999.99% | 0.44% |
| Jan. 5, 2024 | Galbraith Kenneth | Chair & CEO | M | Restricted Stock Unit | 47666 | $0.00 | 95,334.0000 | 68,863,010 | 33.33% | 0.07% |
| Jan. 5, 2024 | Astle Christopher | SVP & Chief Financial Officer | M | Common Stock | 10500 | $0.00 | 12,497.0000 | 68,863,010 | 525.79% | 0.02% |
| Jan. 5, 2024 | Galbraith Kenneth | Chair & CEO | S | Common Stock | 18198 | $10.65 | 29,468.0000 | 68,863,010 | 38.18% | 0.03% |
| Jan. 5, 2024 | Galbraith Kenneth | Chair & CEO | M | Common Stock | 47666 | $0.00 | 47,666.0000 | 68,863,010 | 9999.99% | 0.07% |
| Dec. 26, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Pre-Funded Warrants | 5086521 | $9.83 | 5,086,521.0000 | 65,249,184 | 9999.99% | 7.80% |
| Dec. 11, 2023 | Astle Christopher | SVP & Chief Financial Officer | S | Common Stock | 886 | $9.13 | 1,997.0000 | 65,249,184 | 30.73% | 0.00% |
| Dec. 11, 2023 | Astle Christopher | SVP & Chief Financial Officer | M | Restricted Stock Unit | 1550 | $0.00 | 0.0000 | 65,249,184 | 100.00% | 0.00% |
| Dec. 11, 2023 | Astle Christopher | SVP & Chief Financial Officer | M | Common Stock | 1550 | $0.00 | 2,883.0000 | 65,249,184 | 116.28% | 0.00% |
| Dec. 7, 2023 | Hillan Kenneth J. | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | Campoy Carlos | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | RENTON HOLLINGS | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | Neu Kelvin | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | Cox Troy | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | Mahony Susan | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | Miller Derek John Michael | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| Dec. 7, 2023 | Davidson Nancy | Not found | A | Stock Option (Right to Buy) | 74000 | $0.00 | 74,000.0000 | 65,249,184 | 9999.99% | 0.11% |
| June 30, 2023 | Campoy Carlos | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 65,249,184 | 9999.99% | 0.08% |
| June 16, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 3350000 | $8.12 | 13,437,473.0000 | 65,249,184 | 33.21% | 5.13% |
| April 10, 2023 | Miller Derek John Michael | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 65,249,184 | 9999.99% | 0.08% |
| March 28, 2023 | EcoR1 Capital, LLC | Not found | P | Common Stock | 200000 | $8.00 | 10,087,473.0000 | 65,249,184 | 2.02% | 0.31% |
| March 10, 2023 | Klompas Neil A | President & COO | M | Common Stock | 2708 | $0.00 | 20,709.0000 | 65,249,184 | 15.04% | 0.00% |
| March 10, 2023 | Klompas Neil A | President & COO | M | Restricted Stock Unit | 2708 | $0.00 | 2,709.0000 | 65,249,184 | 49.99% | 0.00% |
| March 10, 2023 | Klompas Neil A | President & COO | M | Restricted Stock Unit | 2500 | $0.00 | 0.0000 | 65,249,184 | 100.00% | 0.00% |
| March 10, 2023 | Klompas Neil A | President & COO | S | Common Stock | 2977 | $7.83 | 17,732.0000 | 65,249,184 | 14.38% | 0.00% |
| March 10, 2023 | Klompas Neil A | President & COO | M | Common Stock | 2500 | $0.00 | 18,001.0000 | 65,249,184 | 16.13% | 0.00% |
| Jan. 19, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 144100 | $9.49 | 9,724,073.0000 | 65,249,184 | 1.50% | 0.22% |
| Jan. 20, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 163400 | $9.88 | 9,887,473.0000 | 65,249,184 | 1.68% | 0.25% |
| Jan. 13, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 342100 | $9.81 | 8,936,973.0000 | 65,249,184 | 3.98% | 0.52% |
| Jan. 17, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 440000 | $9.80 | 9,376,973.0000 | 65,249,184 | 4.92% | 0.67% |
| Jan. 18, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 203000 | $10.00 | 9,579,973.0000 | 65,249,184 | 2.16% | 0.31% |
| Jan. 10, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 920000 | $7.65 | 8,488,573.0000 | 65,249,184 | 12.16% | 1.41% |
| Jan. 11, 2023 | EcoR1 Capital, LLC | TenPercentOwner | P | Common Stock | 106300 | $7.87 | 8,594,873.0000 | 65,249,184 | 1.25% | 0.16% |
| Jan. 5, 2023 | Moore Paul Andrew | Chief Scientific Officer | A | Restricted Stock Unit | 51500 | $0.00 | 51,500.0000 | 65,249,184 | 9999.99% | 0.08% |
| Jan. 5, 2023 | Moore Paul Andrew | Chief Scientific Officer | A | Stock Option (Right to Buy) | 77500 | $0.00 | 77,500.0000 | 65,249,184 | 9999.99% | 0.12% |
| Jan. 5, 2023 | Klompas Neil A | President & COO | A | Stock Option (Right to Buy) | 87500 | $0.00 | 87,500.0000 | 65,249,184 | 9999.99% | 0.13% |
| Jan. 5, 2023 | Klompas Neil A | President & COO | A | Restricted Stock Unit | 58500 | $0.00 | 58,500.0000 | 65,249,184 | 9999.99% | 0.09% |
| Jan. 5, 2023 | Astle Christopher | SVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 47000 | $0.00 | 47,000.0000 | 65,249,184 | 9999.99% | 0.07% |
| Jan. 5, 2023 | Astle Christopher | SVP & Chief Financial Officer | A | Restricted Stock Unit | 31500 | $0.00 | 31,500.0000 | 65,249,184 | 9999.99% | 0.05% |
| Jan. 5, 2023 | Galbraith Kenneth | Chair & CEO | A | Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 65,249,184 | 9999.99% | 0.33% |
| Jan. 5, 2023 | Galbraith Kenneth | Chair & CEO | A | Restricted Stock Unit | 143000 | $0.00 | 143,000.0000 | 65,249,184 | 9999.99% | 0.22% |